Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ascendis Pharma A (ASND) Inventory (2021 - 2025)

Historic Inventory for Ascendis Pharma A (ASND) over the last 4 years, with Q4 2024 value amounting to $315.9 million.

  • Ascendis Pharma A's Inventory rose 4052.06% to $315.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $315.9 million, marking a year-over-year increase of 4052.06%. This contributed to the annual value of $319.9 million for FY2024, which is 4232.78% up from last year.
  • Latest data reveals that Ascendis Pharma A reported Inventory of $315.9 million as of Q4 2024, which was up 4052.06% from $224.8 million recorded in Q4 2023.
  • Ascendis Pharma A's 5-year Inventory high stood at $315.9 million for Q4 2024, and its period low was $86.3 million during Q4 2021.
  • For the 4-year period, Ascendis Pharma A's Inventory averaged around $190.1 million, with its median value being $179.1 million (2022).
  • In the last 5 years, Ascendis Pharma A's Inventory skyrocketed by 6861.63% in 2023 and then skyrocketed by 4052.06% in 2024.
  • Quarter analysis of 4 years shows Ascendis Pharma A's Inventory stood at $86.3 million in 2021, then skyrocketed by 54.55% to $133.3 million in 2022, then skyrocketed by 68.62% to $224.8 million in 2023, then soared by 40.52% to $315.9 million in 2024.
  • Its Inventory was $315.9 million in Q4 2024, compared to $224.8 million in Q4 2023 and $133.3 million in Q4 2022.